HighVista Strategies LLC
13F Reported Value
ⓘ$438.6M
Holdings
147
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
HighVista Strategies LLC disclosed 147 positions worth $438.6M in its Form 13F-HR for Q2 2026, led by $DBC (Invesco DB Commodity Index Tracking Fund) at 6.4% of the equity portfolio, followed by $ABVX and $RVMD. During the quarter the fund opened 29 new positions and exited 38 — including a new stake in $CCCC and a full exit from $TERN. The portfolio is most concentrated in Healthcare (70.4% of disclosed assets). All figures are sourced directly from HighVista Strategies LLC’s Form 13F-HR filing with the SEC under CIK 1335325.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- $28.2M1,057,238 sh
- —
Quality
$15.1M113,031 sh - —
Quality
$12.5M66,983 sh - —
Quality
$11.4M242,884 sh - —
Quality
$10.7M277,873 sh - $10.1M30,210 sh
- 19.5
Quality
$9.5M506,235 sh - —
Quality
$9.4M179,256 sh - —
Quality
$8.7M149,739 sh - 17.6
Quality
$8.1M260,070 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $28.2M | 1,057,238 | |
| — | $15.1M | 113,031 | |
| — | $12.5M | 66,983 | |
| — | $11.4M | 242,884 | |
| — | $10.7M | 277,873 | |
| — | $10.1M | 30,210 | |
| 19.5 | $9.5M | 506,235 | |
| — | $9.4M | 179,256 | |
| — | $8.7M | 149,739 | |
| 17.6 | $8.1M | 260,070 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of HighVista Strategies LLC's 147 positions.
Showing top 10 of 147 holdings.
Sector Allocation
Healthcare
$309.0M
Financials
$42.1M
Technology
$35.8M
Industrials
$17.8M
Consumer Discretionary
$13.3M
Utilities
$9.3M
Energy
$5.8M
Materials
$3.9M
Full Holdings — HighVista Strategies LLC (Q2 2026)
All 147 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Invesco DB Commodity Index Tracking Fund | $28.2M | 6.4% | +0% | — | |
| 2 | Abivax S.A. | $15.1M | 3.4% | -0% | — | |
| 3 | Revolution Medicines, Inc. | $12.5M | 2.9% | -3% | — | |
| 4 | Definium Therapeutics, Inc. | $11.4M | 2.6% | +31% | — | |
| 5 | Immunovant, Inc. | $10.7M | 2.4% | +23% | — | |
| 6 | Praxis Precision Medicines, Inc. | $10.1M | 2.3% | +15% | — | |
| 7 | Relay Therapeutics, Inc. | $9.5M | 2.2% | +20% | 19.5 | |
| 8 | Alkermes plc. | $9.4M | 2.1% | +145% | — | |
| 9 | Vaxcyte, Inc. | $8.7M | 2.0% | +20% | — | |
| 10 | Tango Therapeutics, Inc. | $8.1M | 1.9% | +150% | 17.6 | |
| 11 | Liquidia Corp | $7.8M | 1.8% | -2% | 78.3 | |
| 12 | Cogent Biosciences, Inc. | $7.3M | 1.7% | -4% | — | |
| 13 | Structure Therapeutics Inc. | $7.0M | 1.6% | +6% | — | |
| 14 | Enliven Therapeutics, Inc. | $7.0M | 1.6% | +89% | — | |
| 15 | Amylyx Pharmaceuticals, Inc. | $6.9M | 1.6% | +10% | 8.7 | |
| 16 | Spyre Therapeutics, Inc. | $6.9M | 1.6% | -47% | — | |
| 17 | LB PHARMACEUTICALS INC | $6.9M | 1.6% | +22% | — | |
| 18 | CYTOKINETICS INC | $6.6M | 1.5% | +33% | 28.1 | |
| 19 | C4 Therapeutics, Inc. | $6.3M | 1.4% | NEW | 18.2 | |
| 20 | Tyra Biosciences, Inc. | $5.9M | 1.4% | +41% | — | |
| 21 | ALUMIS INC. | $5.6M | 1.3% | +77% | 7.1 | |
| 22 | Pharvaris N.V. | $5.5M | 1.3% | +64% | — | |
| 23 | Tarsus Pharmaceuticals, Inc. | $5.5M | 1.3% | +66% | 55 | |
| 24 | COMPASS Pathways plc | $5.3M | 1.2% | +2% | — | |
| 25 | Dianthus Therapeutics, Inc. /DE/ | $5.0M | 1.1% | +44% | 22.6 | |
| 26 | Nurix Therapeutics, Inc. | $4.9M | 1.1% | -10% | 6.4 | |
| 27 | Axsome Therapeutics, Inc. | $4.9M | 1.1% | -1% | 40.8 | |
| 28 | Travere Therapeutics, Inc. | $4.9M | 1.1% | +137% | 56.6 | |
| 29 | Vera Therapeutics, Inc. | $4.5M | 1.0% | +53% | — | |
| 30 | NVIDIA CORP | $4.4M | 1.0% | -3% | 85.9 | |
| 31 | GH Research PLC | $4.3M | 1.0% | -26% | — | |
| 32 | PALISADE BIO, INC. | $4.2M | 1.0% | +1% | — | |
| 33 | ARGENX SE | $4.2M | 1.0% | -7% | — | |
| 34 | Maze Therapeutics, Inc. | $4.1M | 0.9% | +37% | 10.3 | |
| 35 | OCULAR THERAPEUTIX, INC | $4.0M | 0.9% | -7% | 8.4 | |
| 36 | Oruka Therapeutics, Inc. | $4.0M | 0.9% | -47% | — | |
| 37 | Dyne Therapeutics, Inc. | $3.8M | 0.9% | -6% | — | |
| 38 | Edgewise Therapeutics, Inc. | $3.7M | 0.8% | -1% | — | |
| 39 | MoonLake Immunotherapeutics | $3.7M | 0.8% | -3% | — | |
| 40 | INSMED Inc | $3.3M | 0.8% | +29% | 39.4 | |
| 41 | Celldex Therapeutics, Inc. | $3.2M | 0.7% | -3% | 8.4 | |
| 42 | AMAZON COM INC | $3.2M | 0.7% | -40% | 68.7 | |
| 43 | Inventiva S.A. | $3.1M | 0.7% | +35% | — | |
| 44 | Talen Energy Corp | $3.1M | 0.7% | +161% | 57.2 | |
| 45 | RELMADA THERAPEUTICS, INC. | $3.1M | 0.7% | NEW | — | |
| 46 | Protagonist Therapeutics, Inc | $3.0M | 0.7% | -28% | 59.4 | |
| 47 | Erasca, Inc. | $2.9M | 0.7% | -11% | — | |
| 48 | Viridian Therapeutics, Inc.\DE | $2.9M | 0.7% | +19% | 27.2 | |
| 49 | Hewlett Packard Enterprise Co | $2.7M | 0.6% | -34% | 70.5 | |
| 50 | Mineralys Therapeutics, Inc. | $2.3M | 0.5% | +84% | — | |
| 51 | Guardant Health, Inc. | $2.3M | 0.5% | -34% | 39 | |
| 52 | Avalo Therapeutics, Inc. | $2.3M | 0.5% | +109% | 11.7 | |
| 53 | James Hardie Industries plc | $2.2M | 0.5% | +30% | — | |
| 54 | EyePoint, Inc. | $2.2M | 0.5% | -15% | 3.5 | |
| 55 | MASTEC INC | $2.1M | 0.5% | +42% | 58.8 | |
| 56 | Xenon Pharmaceuticals Inc. | $2.1M | 0.5% | -28% | 24 | |
| 57 | RBC Bearings INC | $2.1M | 0.5% | +21% | 66.8 | |
| 58 | VISA INC. | $2.0M | 0.5% | -17% | 82.9 | |
| 59 | ASSEMBLY BIOSCIENCES, INC. | $2.0M | 0.5% | -2% | 41.5 | |
| 60 | Stoke Therapeutics, Inc. | $2.0M | 0.5% | -2% | 24.9 | |
| 61 | Olema Pharmaceuticals, Inc. | $2.0M | 0.5% | +36% | — | |
| 62 | Rocket Companies, Inc. | $2.0M | 0.5% | +36% | 74.2 | |
| 63 | XPO, Inc. | $2.0M | 0.5% | +8% | 58.4 | |
| 64 | WESTERN DIGITAL CORP | $1.9M | 0.4% | -26% | 80.7 | |
| 65 | Core Scientific, Inc./tx | $1.9M | 0.4% | -27% | 14.1 | |
| 66 | TEXAS INSTRUMENTS INC | $1.9M | 0.4% | NEW | 73.4 | |
| 67 | KBR, INC. | $1.9M | 0.4% | +38% | 56.2 | |
| 68 | FLOWSERVE CORP | $1.9M | 0.4% | +0% | 70.7 | |
| 69 | Alphabet Inc. | $1.8M | 0.4% | -6% | 78.2 | |
| 70 | Seagate Technology Holdings plc | $1.8M | 0.4% | -36% | — | |
| 71 | Mirum Pharmaceuticals, Inc. | $1.7M | 0.4% | -4% | 35 | |
| 72 | DNOW Inc. | $1.7M | 0.4% | NEW | 48.8 | |
| 73 | ON SEMICONDUCTOR CORP | $1.7M | 0.4% | -35% | 55 | |
| 74 | NUCOR CORP | $1.7M | 0.4% | NEW | 61.7 | |
| 75 | USA TODAY Co., Inc. | $1.6M | 0.4% | NEW | 37.5 | |
| 76 | Broadcom Inc. | $1.6M | 0.4% | -25% | 84.5 | |
| 77 | Calumet, Inc. /DE | $1.6M | 0.4% | NEW | 40.2 | |
| 78 | Qnity Electronics, Inc. | $1.6M | 0.4% | NEW | 68.4 | |
| 79 | Kodiak Sciences Inc. | $1.6M | 0.4% | -7% | — | |
| 80 | Credo Technology Group Holding Ltd | $1.6M | 0.4% | NEW | 55.1 | |
| 81 | Knight-Swift Transportation Holdings Inc. | $1.6M | 0.4% | -12% | 54.4 | |
| 82 | BRINKS CO | $1.6M | 0.3% | NEW | 56.7 | |
| 83 | Astera Labs, Inc. | $1.5M | 0.3% | NEW | 75.1 | |
| 84 | S&P Global Inc. | $1.5M | 0.3% | NEW | 76.1 | |
| 85 | MADRIGAL PHARMACEUTICALS, INC. | $1.5M | 0.3% | +10% | 40.7 | |
| 86 | EQUIFAX INC | $1.5M | 0.3% | NEW | 64.8 | |
| 87 | RHYTHM PHARMACEUTICALS, INC. | $1.5M | 0.3% | -19% | 33.9 | |
| 88 | Savara Inc | $1.5M | 0.3% | -3% | — | |
| 89 | DOMINOS PIZZA INC | $1.5M | 0.3% | NEW | 60.1 | |
| 90 | BELITE BIO, INC | $1.5M | 0.3% | +19% | — | |
| 91 | MICRON TECHNOLOGY INC | $1.5M | 0.3% | -67% | 86.2 | |
| 92 | CIENA CORP | $1.4M | 0.3% | -45% | 72.9 | |
| 93 | Celcuity Inc. | $1.4M | 0.3% | +3% | — | |
| 94 | QXO, Inc. | $1.4M | 0.3% | +209% | 49 | |
| 95 | Immunocore Holdings plc | $1.4M | 0.3% | -26% | — | |
| 96 | CG Oncology, Inc. | $1.3M | 0.3% | -5% | 27 | |
| 97 | US Foods Holding Corp. | $1.3M | 0.3% | NEW | 58.4 | |
| 98 | TransDigm Group INC | $1.3M | 0.3% | -14% | 68 | |
| 99 | Lumentum Holdings Inc. | $1.3M | 0.3% | -51% | 44.3 | |
| 100 | FIRSTENERGY CORP | $1.2M | 0.3% | NEW | 61.5 | |
| 101 | Mastercard Inc | $1.2M | 0.3% | -18% | 85.1 | |
| 102 | ENTERGY CORP /DE/ | $1.2M | 0.3% | -21% | 59.5 | |
| 103 | Krystal Biotech, Inc. | $1.2M | 0.3% | +79% | 79.2 | |
| 104 | MOODYS CORP /DE/ | $1.2M | 0.3% | NEW | 79.1 | |
| 105 | APPLIED MATERIALS INC /DE | $1.2M | 0.3% | NEW | 72.3 | |
| 106 | XCEL ENERGY INC | $1.2M | 0.3% | +18% | 56.4 | |
| 107 | NEXTERA ENERGY INC | $1.2M | 0.3% | +20% | 64.6 | |
| 108 | UNITED THERAPEUTICS Corp | $1.1M | 0.3% | +38% | 71.3 | |
| 109 | GOLAR LNG LTD | $1.1M | 0.3% | NEW | — | |
| 110 | DoorDash, Inc. | $1.1M | 0.2% | -13% | 71 | |
| 111 | ICICI BANK LTD | $1.0M | 0.2% | +29% | — | |
| 112 | Disc Medicine, Inc. | $1.0M | 0.2% | NEW | — | |
| 113 | AMPHENOL CORP /DE/ | $1.0M | 0.2% | -41% | 79.3 | |
| 114 | Unity Software Inc. | $1.0M | 0.2% | -44% | 38.9 | |
| 115 | Ferguson Enterprises Inc. /DE/ | $990,378 | 0.2% | -11% | 52.2 | |
| 116 | Trevi Therapeutics, Inc. | $989,065 | 0.2% | -1% | — | |
| 117 | STMicroelectronics N.V. | $988,548 | 0.2% | NEW | — | |
| 118 | Septerna, Inc. | $982,496 | 0.2% | NEW | 59.2 | |
| 119 | Full Truck Alliance Co. Ltd. | $981,278 | 0.2% | +57% | — | |
| 120 | BridgeBio Pharma, Inc. | $979,859 | 0.2% | -73% | 36.9 | |
| 121 | ARM HOLDINGS PLC /UK | $957,339 | 0.2% | NEW | — | |
| 122 | TAPESTRY, INC. | $951,470 | 0.2% | NEW | 72.7 | |
| 123 | New Oriental Education & Technology Group Inc. | $942,853 | 0.2% | +67% | — | |
| 124 | Silicon Motion Technology CORP | $933,324 | 0.2% | NEW | — | |
| 125 | APi Group Corp | $929,921 | 0.2% | -18% | 65.4 | |
| 126 | UroGen Pharma Ltd. | $918,822 | 0.2% | -6% | — | |
| 127 | MICROSOFT CORP | $900,097 | 0.2% | -63% | 79.8 | |
| 128 | Zymeworks Inc. | $889,100 | 0.2% | -0% | 8.7 | |
| 129 | ADVANCED ENERGY INDUSTRIES INC | $835,229 | 0.2% | NEW | 61.7 | |
| 130 | Joint Stock Co Kaspi.kz | $814,416 | 0.2% | NEW | — | |
| 131 | HDFC BANK LTD | $798,845 | 0.2% | +18% | — | |
| 132 | Vistra Corp. | $777,287 | 0.2% | NEW | 71.9 | |
| 133 | Janux Therapeutics, Inc. | $743,056 | 0.2% | -2% | 30.1 | |
| 134 | NewAmsterdam Pharma Co N.V. | $708,470 | 0.2% | +4% | — | |
| 135 | Meta Platforms, Inc. | $654,543 | 0.1% | -33% | 79.6 | |
| 136 | MBX Biosciences, Inc. | $642,197 | 0.1% | +1% | — | |
| 137 | Nu Holdings Ltd. | $640,879 | 0.1% | -3% | — | |
| 138 | CytomX Therapeutics, Inc. | $636,866 | 0.1% | -41% | 8.7 | |
| 139 | MERCADOLIBRE INC | $636,521 | 0.1% | -14% | 80.2 | |
| 140 | Constellation Energy Corp | $618,442 | 0.1% | -57% | 59.4 | |
| 141 | NEKTAR THERAPEUTICS | $607,906 | 0.1% | -40% | 9.7 | |
| 142 | AKAMAI TECHNOLOGIES INC | $579,229 | 0.1% | NEW | 59.5 | |
| 143 | Xencor Inc | $431,834 | 0.1% | -49% | 11.6 | |
| 144 | Kymera Therapeutics, Inc. | $427,834 | 0.1% | -1% | 28.4 | |
| 145 | PDD Holdings Inc. | $419,540 | 0.1% | -20% | — | |
| 146 | JD.com, Inc. | $360,873 | 0.1% | +5% | — | |
| 147 | South Bow Corp | $357,868 | 0.1% | -50% | — |
New Positions (29)
Exited Positions (38)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for HighVista Strategies LLC including:
Track HighVista Strategies LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for HighVista Strategies LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: HighVista Strategies LLC
13F Pro is an AI hedge fund tracker and stock research platform. For HighVista Strategies LLC (SEC CIK: 1335325), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in HighVista Strategies LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.